Comparing Keytruda vs Tafinlar
| Keytruda | Tafinlar |
|
|---|
| Keytruda (pembrolizumab) | Tafinlar (dabrafenib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Keytruda is a type of immunotherapy that helps boost the immune system's response against cancer. It may be used to treat many different types of cancer in adults and children and is given by... View more |
Prescription only
Prescribed for Melanoma - Metastatic, Non-Small Cell Lung Cancer, Thyroid Cancer, Solid Tumors. Tafinlar may also be used for purposes not listed in this medication guide. |
Related suggestions Solid Tumors
|
|||||||||||||||
| More about Keytruda (pembrolizumab) | More about Tafinlar (dabrafenib) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Keytruda has an average rating of 3.5 out of 10 from a total of 173 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 67% reported a negative effect. |
Tafinlar has an average rating of 7.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Keytruda side effects in more detail. |
Common side effects include:
See also: Tafinlar side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Keytruda prices |
View all Tafinlar prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
624 hours |
22 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 14 drugs are known to interact with Keytruda:
|
A total of 445 drugs are known to interact with Tafinlar:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
May 29, 2013 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.